go-v.orgdoi

Harnessing the immune system to cure cancer

Yuhui Huang · Translational Cancer Research · 2014

  • DOI 10.21037/2802
  • Publisher AME Publishing Company
  • Type article
  • Issued 2014

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Translational Cancer Research · AME Publishing Company · article · 2014

Abstract

As always, the 2014 American Association for Cancer Research (AACR) annual meeting highlighted the latest and most exciting discoveries covered all aspects of cancer research from around the world. This year’s annual meeting theme: “Harnessing Breakthroughs-Targeting Cures” reflected the great progress being made in translating cancer immunological discoveries from bench to bedside. This meeting report briefly summarized key fundamental knowledge and cutting-edge advances in tumor immunology and immunotherapy. The most recent progression in cancer genomics supports the traditional notion that cancer is immunogenic.

The dynamic interplay among malignant cells, immune cells and the immunosuppressive tumor microenvironment leads to the escape of tumor from host immune surveillance. A variety of approaches, including immune checkpoint blockers, adoptive cell transfer and cancer vaccines, have been developed to breakdown the tumor immune tolerance aiming to eliminate malignant cells. Long-term survival benefits have been reported in several cancer types, while the curative potential of cancer immunotherapies is just starting to be realized.

Open the resolved locator · 10.21037/2802

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 03:27 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://tcr.amegroups.com/article/download/2802/pdf
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.